US2017319490A1PendingUtilityA1
Tamper resistant dosage forms
Est. expiryAug 25, 2026(~0.1 yrs left)· nominal 20-yr term from priority
A61P 29/00A61P 29/02A61P 25/00A61P 25/04A61K 9/28A61K 9/2077A61K 9/2027A61K 9/16A61J 3/06A61K 9/2031A61K 9/1641A61K 31/485A61K 9/0002A61K 9/0053B29C 2035/1658B29C 43/52A61J 3/005A61K 9/2853A61K 9/2086A61K 9/284B29B 7/02A61K 9/2866A61K 47/10A61K 45/06B29C 37/0025B29K 2071/02A61K 9/2013B29C 71/009B29C 2035/046A61K 9/2893B29C 43/02B29K 2105/251A61K 47/34A61K 9/2095B29L 2031/753A61J 3/10B29C 35/045A61K 9/209B29K 2995/0088A61K 9/2054A61K 9/2072B29C 35/16B29B 7/88A61K 9/2018B29C 43/003B29K 2105/0035B29C 71/00
75
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to pharmaceutical dosage forms, for example to a tamper resistant dosage form including an opioid analgesic, and processes of manufacture, uses, and methods of treatment thereof.
Claims
exact text as granted — not AI-modified1 - 169 . (canceled)
170 . A process of preparing a cured shaped extended release tablet comprising
(1) an opioid or a pharmaceutically acceptable salt thereof, (2) at least one low molecular weight polyethylene oxide having, based on rheological measurements, an approximate molecular weight of less than 1,000,000, and (3) at least one high molecular weight polyethylene oxide having, based on rheological measurements, an approximate molecular weight of 7,000,000; said process comprising the steps of: (a) providing a first combination comprising said high molecular weight polyethylene oxide and said opioid or pharmaceutically acceptable salt thereof; and (b) providing a second combination comprising said low molecular weight polyethylene oxide and optionally comprising said opioid or pharmaceutically acceptable salt thereof; and (c) forming a shaped tablet comprising the first and second combinations; (d) curing said shaped tablet by applying a temperature from about 60° C. to about 90° C. for a time of from about 15 minutes to about 10 hours; and (e) optionally applying one or more coatings to said shaped tablet; wherein the total combined weight of said high and low molecular weight polyethylene oxides is at least 79% by weight, and said percent by weight is based upon the total weight of said shaped tablet, not including the combined weight of said coatings.
171 . A process of preparing a cured shaped tablet as defined in claim 170 , wherein the percent by weight of said opioid or pharmaceutically acceptable salt is at least 2.4%.
172 . A process of preparing a cured shaped tablet as defined in claim 170 , wherein said time in said curing step is 15 minutes to 60 minutes.
173 . A process of preparing a cured shaped tablet as defined in claim 170 , wherein said temperature in said curing step is from about 70° C. to about 78° C.
174 . A process of preparing a cured shaped extended release tablet comprising
(1) hydrocodone or a pharmaceutically acceptable salt thereof, (2) at least one low molecular weight polyethylene oxide having, based on rheological measurements, an approximate molecular weight of less than 1,000,000, and (3) at least one high molecular weight polyethylene oxide having, based on rheological measurements, an approximate molecular weight of 7,000,000; said process comprising the steps of: (a) providing a first combination comprising said high molecular weight polyethylene oxide and said opioid or pharmaceutically acceptable salt thereof; and (b) providing a second combination comprising said low molecular weight polyethylene oxide and optionally comprising said opioid or pharmaceutically acceptable salt thereof; and (c) forming a shaped tablet comprising the first and second combinations; (d) curing said shaped tablet by applying a temperature from about 60° C. to about 90° C. for a time of from about 15 minutes to about 10 hours; and (e) optionally applying one or more coatings to said shaped tablet; wherein said low molecular weight polyethylene oxide is at least 20% by weight, and the total combined weight of said high and low molecular weight polyethylene oxides is at least 79% by weight, and said percent by weight is based upon the total weight of said shaped tablet, not including the combined weight of said coatings.
175 . A process of preparing a cured shaped tablet as defined in claim 174 , wherein said time in said curing step is 15 minutes to 60 minutes.
176 . A process of preparing a cured shaped tablet as defined in claim 174 , wherein, said temperature in said curing step is from about 70° C. to about 78° C.
177 . A process of preparing a cured shaped tablet as defined in claim 174 , wherein the percent by weight of said low molecular weight polyethylene oxide is at least 29% and the percent by weight of said high molecular weight polyethylene oxide is at least 50%.
178 . A process of preparing a cured shaped tablet as defined in claim 174 , wherein the percent by weight of said hydrocodone or pharmaceutically acceptable salt thereof is at least 2.4%.
179 . A process of preparing a cured shaped tablet as defined in claim 174 , wherein the percent by weight of said hydrocodone or pharmaceutically acceptable salt thereof is at least 5%.
180 . A process of preparing a cured shaped tablet as defined in claim 174 , wherein the percent by weight of said hydrocodone or pharmaceutically acceptable salt thereof is at least 10%.
181 . A process of preparing a cured shaped tablet as defined in claim 177 , wherein said temperature in said curing step is from about 70° C. to about 78° C.
182 . A process of preparing a cured shaped tablet as defined in claim 177 , wherein said time in said curing step is 15 minutes to 60 minutes.
183 . A process of preparing a cured shaped tablet as defined in claim 177 , wherein said temperature in said curing step is from about 70° C. to about 78° C. and said time in said curing step is 15 minutes to 60 minutes.
184 . A process of preparing a cured shaped tablet as defined in claim 178 , wherein said temperature in said curing step is from about 70° C. to about 78° C.
185 . A process of preparing a cured shaped tablet as defined in claim 178 , wherein said time in said curing step is 15 minutes to 60 minutes.
186 . A process of preparing a cured shaped tablet as defined in claim 178 , wherein said temperature in said curing step is from about 70° C. to about 78° C. and said time in said curing step is 15 minutes to 60 minutes.
187 . A process of preparing a cured shaped tablet as defined in claim 179 , wherein the percent by weight of said high molecular weight polyethylene oxide is at least 54%.
188 . A process of preparing a cured shaped tablet as defined in claim 174 , wherein the total combined weight of said high and low molecular weight polyethylene oxides is at least 80% by weight.
189 . A process of preparing a cured shaped tablet as defined in claim 174 , wherein the total combined weight of said high and low molecular weight polyethylene oxides is at least 90% by weight.
190 . A process of preparing a cured shaped tablet as defined in claim 178 , wherein the total combined weight of said high and low molecular weight polyethylene oxides is at least 80% by weight.
191 . A process of preparing a cured shaped tablet as defined in claim 178 , wherein the total combined weight of said high and low molecular weight polyethylene oxides is at least 85% by weight.
192 . A process of preparing a cured shaped tablet as defined in claim 178 , wherein the total combined weight of said high and low molecular weight polyethylene oxides is at least 90% by weight.
193 . A process of preparing a cured shaped tablet as defined in claim 170 , wherein said curing comprises convection curing in a convection curing device.
194 . A process of preparing a cured shaped tablet as defined in claim 183 , wherein said curing comprises convection curing in a convection curing device.
195 . A process of preparing a cured shaped tablet as defined in claim 194 , wherein said curing temperature is measured as a mean exhaust temperature of said convection curing device during said curing time.
196 . A process of preparing a cured shaped tablet as defined in claim 174 , wherein said cured shaped tablet has a density that is at least about 1% lower than the density of said shaped tablet prior to curing.
197 . A process of preparing a cured shaped tablet as defined in claim 177 , wherein said cured shaped tablet has a density that is at least about 1% lower than the density of said shaped tablet prior to curing.
198 . A process of preparing a cured shaped tablet as defined in claim 195 , wherein said cured shaped tablet has a density that is at least about 1% lower than the density of said shaped tablet prior to curing.
199 . A process of preparing a cured shaped tablet as defined in claim 186 , wherein the percent by weight of said high molecular weight polyethylene oxide is at least 54%, and wherein said cured shaped tablet has a density that is at least about 1% lower than the density of said shaped tablet prior to curing.Join the waitlist — get patent alerts
Track US2017319490A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.